Can risk groups accurately predict non‐sentinel lymph node metastasis in sentinel lymph node‐positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO‐SLN‐004)
- 1 December 2020
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 123 (2) , 638-645
Abstract
Background and Objectives: The purpose of this study was to find out the risk factors associated with non‐sentinel lymph node metastasis and determine the incidence of non‐sentinel lymph node metastasis according to risk groups in sentinel lymph node (SLN)‐positive endometrial cancer patients.Methods: Patients who underwent at least bilateral pelvic lymphadenectomy after SLN mapping were retrospectively analyzed. Patients were categorized into low, intermediate, high‐intermediate, and high‐risk groups defined by ESMO‐ESGO‐ESTRO.Results: Out of 395 eligible patients, 42 patients had SLN metastasis and 16 (38.1%) of them also had non‐SLN metastasis. Size of SLN metastasis was the only factor associated with non‐SLN metastasis (p = .012) as 13/22 patients with macrometastasis, 2/10 with micrometastasis and 1/10 with isolated tumor cells (ITCs) had non‐SLN metastasis. Although all 4 metastases (1.8%) among the low‐risk group were limited to SLNs, the non‐SLN involvement rate in the high‐risk group was 42.9% and all of these were seen in patients with macrometastatic SLNs.Conclusions: Non‐SLN metastasis was more frequent in higher‐risk groups and the risk of non‐SLN metastasis increased with the size of SLN metastasis. Proceeding to complete lymphadenectomy when SLN is metastatic should further be studied as the effect of leaving metastatic non‐SLNs in‐situ is not known.Keywords
This publication has 28 references indexed in Scilit:
- Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomyGynecologic Oncology, 2020
- Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithmGynecologic Oncology, 2019
- Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysisGynecologic Oncology, 2019
- The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian studyEuropean Journal of Surgical Oncology, 2018
- Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2017
- Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node MappingAnnals of Surgical Oncology, 2017
- A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort studyThe Lancet Oncology, 2017
- Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasionGynecologic Oncology, 2016
- Survival advantage of lymphadenectomy in endometrial cancerJournal of Cancer Research and Clinical Oncology, 2016
- Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysisThe Lancet, 2010